• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Will an International Qualitative Study of Crohn's Disease Patient Experiences and Preferences Evolve the Future of Disease Monitoring?一项关于克罗恩病患者经历和偏好的国际定性研究能否推动疾病监测的未来发展？
Crohns Colitis 360. 2023 Feb 25;5(2):otad013. doi: 10.1093/crocol/otad013. eCollection 2023 Apr.
2
Crohn's Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study.克罗恩病患者对疾病监测的体验与偏好：一项国际定性研究。
Crohns Colitis 360. 2023 Feb 25;5(2):otad012. doi: 10.1093/crocol/otad012. eCollection 2023 Apr.
3
Regaining normality: A grounded theory study of the illness experiences of Chinese patients living with Crohn's disease.恢复常态：一项扎根理论研究，探讨中国克罗恩病患者的患病体验。
Int J Nurs Stud. 2019 May;93:87-96. doi: 10.1016/j.ijnurstu.2019.02.015. Epub 2019 Mar 5.
4
A Qualitative Exploration of the Lived Experiences of Patients Before and After Ileostomy Creation as a Result of Surgical Management for Crohn's Disease.对因克罗恩病手术治疗而行回肠造口术的患者造口前后生活经历的质性探索。
Ostomy Wound Manage. 2017 Jan;63(1):34-39.
5
The informational and decisional preferences of patients undergoing surgery for Crohn's anal fistula: a qualitative study.克罗恩病肛瘘手术患者的信息及决策偏好：一项定性研究
Colorectal Dis. 2020 Jun;22(6):703-712. doi: 10.1111/codi.14936. Epub 2020 Jan 9.
6
Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn's disease: study protocol for a randomised controlled trial.高强度间歇训练和中等强度持续训练对非活动期或轻度活动期克罗恩病成人患者的可行性：一项随机对照试验的研究方案
Pilot Feasibility Stud. 2017 Apr 3;3:17. doi: 10.1186/s40814-017-0133-z. eCollection 2017.
7
Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.预测生物标志物识别可能发展为严重克罗恩病的患者：系统评价。
Health Technol Assess. 2021 Jul;25(45):1-66. doi: 10.3310/hta25450.
8
Understanding life experiences of people affected by Crohn's disease in Spain. A phenomenological approach.了解西班牙克罗恩病患者的生活经历：一种现象学方法。
Scand J Caring Sci. 2018 Mar;32(1):354-362. doi: 10.1111/scs.12469. Epub 2017 Sep 4.
9
A SPECIAL MEETING REVIEW EDITION: Highlights in Inflammatory Bowel Disease From the 14th Congress of ECCO: A Review of Selected Presentations From the 14th Congress of the European Crohn's and Colitis Organisation (ECCO) • March 6-9, 2019 • Copenhagen, Denmark• VARSITY: A Double-Blind, Double-Dummy, Randomized Controlled Trial of Vedolizumab Versus Adalimumab in Patients With Active Ulcerative Colitis• Analyses of Data From the VISIBLE 1 and 2 Trials: Vedolizumab in Patients With Ulcerative Colitis or Crohn's Disease• Improved Endoscopic Outcomes and Mucosal Healing of Upadacitinib as an Induction Therapy in Adults With Moderately to Severely Active Ulcerative Colitis: Data From the U-ACHIEVE Study• Long-Term Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease: Final Results From the GEMINI LTS Study• Pediatric Crohn's Disease Adalimumab Level-Based Optimization Treatment (PAILOT) Randomized Controlled Trial• Maintenance Treatment With Mirikizumab, a P19-Directed IL-23 Antibody: 52-Week Results in Patients With Moderately to Severely Active Ulcerative Colitis• Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF Therapy in Biologic-Naive Patients With Ulcerative Colitis or Crohn's Disease: Results From the EVOLVE Study• A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of a Targeted-Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Efficacy Results• Real-World Analyses of Patients With IBD Treated With Vedolizumab Professor of MedicineDivision of Gastroenterology and HepatologyMayo ClinicRochester, Minnesota.特别会议回顾版：欧洲克罗恩病和结肠炎组织（ECCO）第14届大会炎症性肠病亮点：对第14届欧洲克罗恩病和结肠炎组织（ECCO）大会部分演讲的回顾 • 2019年3月6 - 9日 • 丹麦哥本哈根• VARSITY：维多珠单抗与阿达木单抗治疗活动性溃疡性结肠炎患者的双盲、双模拟、随机对照试验• 来自VISIBLE 1和2试验的数据分析：维多珠单抗治疗溃疡性结肠炎或克罗恩病患者• 乌帕替尼作为中度至重度活动性溃疡性结肠炎成人诱导治疗的内镜结果改善和黏膜愈合：U - ACHIEVE研究数据• 维多珠单抗治疗溃疡性结肠炎和克罗恩病的长期安全性：GEMINI LTS研究最终结果• 儿童克罗恩病阿达木单抗基于水平的优化治疗（PAILOT）随机对照试验• 抗P19导向的IL - 23抗体mirikizumab维持治疗：中度至重度活动性溃疡性结肠炎患者52周结果• 维多珠单抗和抗TNF治疗在初治溃疡性结肠炎或克罗恩病患者中的真实世界有效性和安全性：EVOLVE研究结果• 靶向释放口服环孢素制剂治疗轻至中度溃疡性结肠炎的随机、多中心、双盲、安慰剂对照研究：疗效结果• 接受维多珠单抗治疗的炎症性肠病患者的真实世界分析 医学教授 胃肠病学和肝病科 梅奥诊所 明尼苏达州罗切斯特
Gastroenterol Hepatol (N Y). 2019 May;15(5 Suppl 2):1-24.
10
Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.《计算机断层扫描和磁共振肠造影术评估、解读和应用于小肠克罗恩病患者的共识推荐》
Gastroenterology. 2018 Mar;154(4):1172-1194. doi: 10.1053/j.gastro.2017.11.274. Epub 2018 Jan 10.

本文引用的文献

1
Systematic Review: Patient Perceptions of Monitoring Tools in Inflammatory Bowel Disease.系统评价：炎症性肠病患者对监测工具的认知
J Can Assoc Gastroenterol. 2020 Jan 24;4(2):e31-e41. doi: 10.1093/jcag/gwaa001. eCollection 2021 Apr.
2
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.欧洲克罗恩病和结肠炎组织（ECCO）与欧洲胃肠内镜学会（ESGAR）炎症性肠病诊断评估指南 第1部分：初始诊断、已知炎症性肠病的监测、并发症的检测
J Crohns Colitis. 2019 Feb 1;13(2):144-164. doi: 10.1093/ecco-jcc/jjy113.
3
Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application.炎症性肠病的胃肠超声：一种尚未充分利用但具有潜在变革性应用的资源。
Gut. 2018 May;67(5):973-985. doi: 10.1136/gutjnl-2017-315655. Epub 2018 Feb 3.
4
Imaging for luminal disease and complications: CT enterography, MR enterography, small-bowel follow-through, and ultrasound.腔道疾病及并发症的影像学检查：CT 肠造影、MR 肠造影、小肠钡剂造影和超声。
Gastroenterol Clin North Am. 2012 Jun;41(2):497-512. doi: 10.1016/j.gtc.2012.01.015.

Will an International Qualitative Study of Crohn's Disease Patient Experiences and Preferences Evolve the Future of Disease Monitoring?

作者信息

Castrillon Rocio

机构信息

Crohn's & Colitis Foundation, New York, New York, USA.

出版信息

Crohns Colitis 360. 2023 Feb 25;5(2):otad013. doi: 10.1093/crocol/otad013. eCollection 2023 Apr.

DOI:10.1093/crocol/otad013
PMID:36937139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10022719/
Abstract
摘要